BME Price Forecast & CEF Analysis. Distribution · NAV · Discount · Expense Ratio · RSI · MACD | US Stocks Today
Full metrics table
💊 A closed-end fund (CEF) managed by BlackRock that focuses on healthcare sector stocks, this is an income and growth product that invests diversely in health science companies such as pharmaceuticals, biotechnology, and medical devices, while providing monthly distributions.
Against the value of what the fund holds it is 3.1% cheaper.
Its holdings are worth $48.20 per share, but it trades at $46.69. That is close to its past-year average (4.5% below value).
Over the past 1 year, on the higher side
0% below its 1-year high.
Traded more than usual. That is 127% of its average volume.
Ex-dividend date: November 13
8 days to go. Buy before this date to receive the dividend.
Holding long would have paid off
Bought 5 years ago, your return today would be +0.1%. The S&P 500 did +64% over the same period.
Tap to view numbers
Dividends are paid consistently
Pays 6.58% annually in dividends.
Tap to view numbers
Ownership is about average
Institutions hold 20.0%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #590 of 1436 in the industry
Based on market cap of $618M.
FAQ
What kind of CEF is BME?
BME is a closed-end fund (CEF).
What is the distribution yield of BME?
BME's distribution yield is approximately 6.58%, paid out on a regular basis.
What is the NAV of BME?
BME's NAV is $48.20, which can be compared to the market price to determine any discount or premium.
What are the assets under management of BME?
BME's assets under management (AUM) are approximately $607M.
What is the 52-week high and low for BME?
BME has recorded a 52-week high of $47.38 and a low of $37.51.